eXciteOSA®: the only clinically proven daytime therapy to address the root cause of snoring and mild sleep apnoea

“For the first time in many, many decades, I genuinely look forward to going to sleep”

Tim

Clinically Proven Efficacy 80% OF PATIENTS  reported more than 50% REDUCTION in snoring1-3

eXciteOSA® has been clinically proven to improve the quality of sleep by reducing snoring and sleep apnoea significantly, when used for 20 minutes, once a day for 6 weeks1-3

98%
of patients reported reduction in snoring time3
82%
of bed partners reported reduction of their partners snoring3
c. 70%
of sleep apnoea patients achieved reduction in sleep apnoea measures3

“I have been very surprised by this device. The feedback and adherence from the patients have been excellent, reporting an improvement in their snoring. The integration between the app and the device work is smooth, easy and intuitive. Excellent idea!”

Peter M Baptista

Dr. Peter M Baptista, MD, PhD

Clínica Universidad de Navarra, Madrid, Spain
Expert in Sleep and ENT

“I believe that the eXciteOSA® device will play a large role in helping to treat patients with sleep disordered breathing; in particular those with primary snoring, as well as those with mild sleep apnoea, leading to improved sleep quality for both the patient and the partner.”

Professor Bhik Kotecha

Professor Bhik Kotecha

Consultant Ear, Nose and Throat Surgeon
Nuffield Health Brentwood Hospital, London, United Kingdom

With improved sleep quality comes better health, better lives and closer relationships

Take your first steps towards a restful night’s sleep today

References

  1. E.Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52
  2. A.Sama et al. Daytime Intraoral Neurostimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018
  3. Prospective cohort study of 50 patients with snoring or mild OSA (Apnea- Hypopnea Index (AHI) <15) with 46 completed the trial. Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPat night sleep studies before and after the use of the device. An intra-oral tongue stimulator (Snoozeal®) device was used for 20mins, once a day for 6-week period